Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment.

Journal of neurovirology - 1 Dec 2014

Cattie Jordan E, Letendre Scott L, Woods Steven Paul, Barakat Fatma, Perry William, Cherner Mariana, Umlauf Anya, Franklin Donald, Heaton Robert K, Hassanein Tarek, Grant Igor

Abstract excerpt

Treatment of hepatitis C virus (HCV) with pegylated interferon and ribavirin (IFN/RBV) can be associated with neuropsychiatric side effects, which may necessitate dose reductions or treatment discontinuation. This study aimed to characterize the time course and predictors of cognitive and affective/mood symptoms after IFN/RBV treatment initiation. Forty individuals enrolled in a longitudinal project underwent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Affect
Share to Cognition

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Depression

Share to Drug Therapy, Combination

Share to Interferon-alpha

Share to Polyethylene Glycols

Share to Psychological Tests

Share to Ribavirin

Source

Open in PubMed Open full text

Identifiers

PMID: 25326107
DOI: 10.1007/s13365-014-0265-3
PMCID: PMC4367960

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment.PMID 25326107Read ↗

Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015.Semantic proximity Read ↗

Psychiatric problems in patients infected with hepatitis C before and during antiviral treatment with interferon-alpha: a review.Semantic proximity Read ↗

Cognitive Dysfunction and Single Nucleotide Polymorphisms in Hepatitis C Virus-Infected Persons: A Systematic Review.Semantic proximity Read ↗

Cognitive assessment in patients with Hepatitis C submitted to treatment with Sofosbuvir and Simeprevir or Daclatasvir.Semantic proximity Read ↗

Association between apolipoprotein E epsilon4 and neuropsychiatric symptoms during interferon alpha treatment for chronic hepatitis C.Semantic proximity Read ↗

Apolipoprotein E-ε4 deficiency and cognitive function in hepatitis C virus-infected patients.Semantic proximity Read ↗

Longitudinal Cognitive Outcomes of Clinical Phenotypes of Late-Life Depression.Semantic proximity Read ↗

Sustained virological response in the antiviral therapy of chronic hepatitis C: is there a predictive value of interferon-induced depression?Semantic proximity Read ↗

Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose.Semantic proximity Read ↗

Cerebral microglial activation in patients with hepatitis c: in vivo evidence of neuroinflammationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.